140 related articles for article (PubMed ID: 6383328)
1. The use of immunohistochemical probes in the study of benign and malignant breast disease.
Gusterson BA; Warburton MJ; Monaghan P; Foster C; Edwards P; Kraft N; Smith C; Mitchell D; Rudland PS; Neville AM
Behring Inst Mitt; 1984 May; (74):39-48. PubMed ID: 6383328
[TBL] [Abstract][Full Text] [Related]
2. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
3. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.
Gusterson BA; Warburton MJ; Mitchell D; Ellison M; Neville AM; Rudland PS
Cancer Res; 1982 Nov; 42(11):4763-70. PubMed ID: 6290045
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study.
Croce MV; Colussi AG; Price MR; Segal-Eiras A
Anticancer Res; 1997; 17(6D):4287-92. PubMed ID: 9494522
[TBL] [Abstract][Full Text] [Related]
5. c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases.
Polat A
Pathol Res Pract; 2007; 203(11):765-9. PubMed ID: 17931792
[TBL] [Abstract][Full Text] [Related]
6. Epithelial stem cells and their possible role in the development of the normal and diseased human breast.
Rudland PS
Histol Histopathol; 1993 Apr; 8(2):385-404. PubMed ID: 8490267
[TBL] [Abstract][Full Text] [Related]
7. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
Förster C; Bässler R
Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
[No Abstract] [Full Text] [Related]
8. Integrin expression on normal and neoplastic human breast epithelium.
Damjanovich L; Fülöp B; Adány R; Nemes Z
Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
[TBL] [Abstract][Full Text] [Related]
9. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
[TBL] [Abstract][Full Text] [Related]
11. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells.
Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V
J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093
[TBL] [Abstract][Full Text] [Related]
12. [Morpho-functional changes in the basement membrane in benign disease and in preinvasive and microinvasive carcinoma of the breast: immunohistochemical study with anti-collagen IV monoclonal antibody].
Lanzafame S; Puzzo L
Pathologica; 1988; 80(1067):309-18. PubMed ID: 3237440
[No Abstract] [Full Text] [Related]
13. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
Viacava P; Naccarato AG; Collecchi P; Ménard S; Castronovo V; Bevilacqua G
J Pathol; 1997 May; 182(1):36-44. PubMed ID: 9227340
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of HMFG2 in breast carcinomas: an immunohistochemical and immunoelectron microscopic study.
Hanna WM; Kahn HJ; Zive SE; Shackleton M; Andrighetti L
Mod Pathol; 1992 Nov; 5(6):603-6. PubMed ID: 1369793
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
20. Transferrin receptor expression in non-malignant and malignant human breast tissue.
Walker RA; Day SJ
J Pathol; 1986 Mar; 148(3):217-24. PubMed ID: 3009766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
